These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 25173806)

  • 1. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.
    Huang Y; Mahley RW
    Neurobiol Dis; 2014 Dec; 72 Pt A():3-12. PubMed ID: 25173806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases.
    Huang Y
    Curr Opin Lipidol; 2010 Aug; 21(4):337-45. PubMed ID: 20531185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E: from lipid transport to neurobiology.
    Hauser PS; Narayanaswami V; Ryan RO
    Prog Lipid Res; 2011 Jan; 50(1):62-74. PubMed ID: 20854843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
    Butterfield DA; Mattson MP
    Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
    Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
    J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD
    Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer's Disease Risk Reduction and Early Intervention.
    Wu L; Zhang X; Zhao L
    J Neurosci; 2018 Jul; 38(30):6665-6681. PubMed ID: 29967007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.
    Mahley RW
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1305-15. PubMed ID: 27174096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease.
    Lanfranco MF; Ng CA; Rebeck GW
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
    Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
    Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E and Alzheimer disease.
    Huang Y
    Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
    Fagan AM; Holtzman DM
    Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease.
    Lane RM; Farlow MR
    J Lipid Res; 2005 May; 46(5):949-68. PubMed ID: 15716586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E: far more than a lipid transport protein.
    Mahley RW; Rall SC
    Annu Rev Genomics Hum Genet; 2000; 1():507-37. PubMed ID: 11701639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF lipoproteins and Alzheimer's disease.
    Neely MD; Montine TJ
    J Nutr Health Aging; 2002; 6(6):383-91. PubMed ID: 12459889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human apolipoprotein E: the Alzheimer's disease connection.
    Weisgraber KH; Mahley RW
    FASEB J; 1996 Nov; 10(13):1485-94. PubMed ID: 8940294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.